Article
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer
2024-08-19
Abstract excerpt
<h4>Summary</h4> Neuroendocrine prostate cancer (NEPC) presents a formidable clinical challenge owing to its aggressive progression and resistance to conventional therapies. A key driver of NEPC is the overexpression of MYCN , a well-established oncogene associated with neuroendocrine tumors. However, efforts to directly inhibit the N-Myc protein encoded by this gene have resulted in limited success, thereby hin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f89459d9-fe9e-5ee6-9069-c2222830ff77
- DOI
- 10.1101/2024.08.16.607954
